PMM2 and inflammatory bowel disease: Monogenic IBD can cause a severe and treatment resistant disease course, but PMM2-related IBD appears to be relatively mild form of IBD (best classified as IBD-unclassified (IBDU)) and responds to standard treatments (azathioprine, sulfasalazine, infliximab).